Inventor · disambiguated record
Richard J. Youle
Also filed as: YOULE RICHARD J
20 granted patents·6 pending applications·701 citations·filing 1980–2012
96Inventor score
Files withUS HEALTH20DEPT HEALTH & HUMAN SERV1HEALTH AND HUMAN SERVICES NAT1HOTT JONATHAN S1NEVILLE JR DAVID M1
Top patents by PatentIndex Score
26 records- 0194US4359457AAnti Thy 1.2 monoclonal antibody-ricin hybrid utilized as a tumor suppressantNEVILLE JR DAVID M·Filed 1980·Granted Nov 16, 1982·147 cites·3 claims
- 0290US6737511B1Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosisUS HEALTH·Filed 2000·Granted May 18, 2004·33 cites·12 claims
- 0388US5208021AMethod of preparing diphtheria immunotoxinsUS HEALTH·Filed 1989·Granted May 4, 1993·108 cites·14 claims
- 0487US5792458AMutant diphtheria toxin conjugatesUS HEALTH·Filed 1994·Granted Aug 11, 1998·85 cites·39 claims
- 0585US5955073ASelective RNase cytotoxic reagentsUS HEALTH·Filed 1997·Granted Sep 21, 1999·47 cites·12 claims
- 0683US5840840ASelective RNase cytotoxic reagentsUS HEALTH·Filed 1993·Granted Nov 24, 1998·52 cites·7 claims
- 0778US6197528B1Composition of immunotoxins and retinoids and use thereofUS HEALTH·Filed 1999·Granted Mar 6, 2001·33 cites·8 claims
- 0878US4500637APrevention of graft versus host disease following bone marrow transplantationUS HEALTH·Filed 1982·Granted Feb 19, 1985·33 cites·2 claims
- 0973US4440747AMonoclonal antibody-ricin hybrids as a treatment of murine graft-versus-host diseaseUS HEALTH·Filed 1982·Granted Apr 3, 1984·27 cites·2 claims
- 1071US4520226ATreatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugatesUS HEALTH·Filed 1983·Granted May 28, 1985·23 cites·5 claims
- 1169US6780413B2Immunotoxin (mAB-RICIN) for the treatment of focal movement disordersUS HEALTH·Filed 2001·Granted Aug 24, 2004·5 cites·11 claims
- 1266US5728383ATreatment of tumors of the central nervous system with immunotoxinsUS HEALTH·Filed 1994·Granted Mar 17, 1998·34 cites·12 claims
- 1362US6649393B1Mutant form of cytotoxic ribonucleolytic protein which allows production by recombinant methodsUS HEALTH·Filed 1998·Granted Nov 18, 2003·19 cites·8 claims
- 1462US2004152179A1Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosisUS HEALTH·Filed 2004·Application pending·0 cites
- 1562US2009075882A1Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosisHEALTH AND HUMAN SERVICES NAT·Filed 2008·Application pending·0 cites
- 1660US2007243190A1Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosisUS HEALTH·Filed 2007·Application pending·0 cites
- 1758US5352447AImmunotoxins for treatment of intracranial lesions and as adjunct to chemotherapyUS HEALTH·Filed 1992·Granted Oct 4, 1994·20 cites·10 claims
- 1851US2005266010A1Immunotoxin (mAB-RICIN) for the treatment of focal movement disordersHOTT JONATHAN S·Filed 2004·Application pending·0 cites
- 1949US6696064B2Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapyUS HEALTH·Filed 2001·Granted Feb 24, 2004·0 cites·48 claims
- 2049US4356117AChemical modifications of proteins which induce new receptor specificities and therefore elicit new effects in cellsU S GOVT DEPT OF HEALTH & HUMA·Filed 1980·Granted Oct 26, 1982·13 cites·1 claims
- 2145US5942230AComposition of immunotoxins and retinoids and use thereofUS HEALTH·Filed 1994·Granted Aug 24, 1999·11 cites·15 claims
- 2244US2012277286A1Compositions and methods for the treatment or prevention of mitochondrial diseasesYOULE RICHARD J·Filed 2012·Application pending·0 cites
- 2342US4520011AInactivating protein synthesis by incubating anti-Thy 1.1-ricin a chain monoclonal antibody hybrids with target protein cellsUS HEALTH·Filed 1982·Granted May 28, 1985·6 cites·2 claims
- 2439US4397843AMannose-6-phosphate-low density protein reagent effective against hypercholesterolemiaUS HEALTH·Filed 1982·Granted Aug 9, 1983·5 cites·2 claims
- 2531US2010317577A1Methods and Compositions for Inhibiting Cell Death or Enhacing Cell ProliferationDEPT HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 2626US6649392B1Mutant form of a cytotoxic ribonucleolytic protein which allows production by recombinant methodsUS HEALTH·Filed 1996·Granted Nov 18, 2003·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Richard J. Youle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →